PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 92 filers reported holding PUMA BIOTECHNOLOGY INC in Q3 2013. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $25,864,000 | -38.4% | 842,478 | +34.6% | 0.01% | -44.4% |
| Q3 2016 | $41,975,000 | +134.0% | 626,024 | +4.0% | 0.01% | +125.0% |
| Q2 2016 | $17,936,000 | +164.5% | 602,071 | +160.7% | 0.00% | +100.0% |
| Q1 2016 | $6,782,000 | -64.3% | 230,920 | -4.7% | 0.00% | -50.0% |
| Q4 2015 | $19,006,000 | +10.9% | 242,424 | +6.6% | 0.00% | 0.0% |
| Q3 2015 | $17,133,000 | -35.9% | 227,353 | -0.7% | 0.00% | -33.3% |
| Q2 2015 | $26,741,000 | -82.6% | 229,042 | -64.8% | 0.01% | -83.8% |
| Q1 2015 | $153,457,000 | +34.4% | 649,940 | +7.8% | 0.04% | +32.1% |
| Q4 2014 | $114,145,000 | -10.8% | 603,082 | +12.4% | 0.03% | -22.2% |
| Q3 2014 | $127,994,000 | +266.4% | 536,506 | +1.4% | 0.04% | +260.0% |
| Q2 2014 | $34,935,000 | -42.3% | 529,311 | -9.0% | 0.01% | -44.4% |
| Q1 2014 | $60,582,000 | +7.6% | 581,739 | +7.0% | 0.02% | +5.9% |
| Q4 2013 | $56,278,000 | +84.0% | 543,593 | -4.7% | 0.02% | +70.0% |
| Q3 2013 | $30,593,000 | +36.8% | 570,135 | +13.1% | 0.01% | +25.0% |
| Q2 2013 | $22,367,000 | – | 504,098 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |